AU6321899A - The use of dopaminergic agents in the management of sexual dysfunction - Google Patents

The use of dopaminergic agents in the management of sexual dysfunction

Info

Publication number
AU6321899A
AU6321899A AU63218/99A AU6321899A AU6321899A AU 6321899 A AU6321899 A AU 6321899A AU 63218/99 A AU63218/99 A AU 63218/99A AU 6321899 A AU6321899 A AU 6321899A AU 6321899 A AU6321899 A AU 6321899A
Authority
AU
Australia
Prior art keywords
management
sexual dysfunction
dopaminergic agents
dopaminergic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63218/99A
Inventor
George Karpati
Maria Jutka Molnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU6321899A publication Critical patent/AU6321899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63218/99A 1998-10-20 1999-10-20 The use of dopaminergic agents in the management of sexual dysfunction Abandoned AU6321899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2251255 CA2251255A1 (en) 1998-10-20 1998-10-20 The use of dopaminergic agents in the management of sexual dysfunction
CA2251255 1998-10-20
PCT/CA1999/000977 WO2000023056A2 (en) 1998-10-20 1999-10-20 The use of dopaminergic agents in the management of sexual dysfunction

Publications (1)

Publication Number Publication Date
AU6321899A true AU6321899A (en) 2000-05-08

Family

ID=4162940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63218/99A Abandoned AU6321899A (en) 1998-10-20 1999-10-20 The use of dopaminergic agents in the management of sexual dysfunction

Country Status (3)

Country Link
AU (1) AU6321899A (en)
CA (1) CA2251255A1 (en)
WO (1) WO2000023056A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775102B2 (en) * 1999-09-13 2004-07-15 David M. Swope Composition and method for decreasing neurologic symptomatology

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
US6960589B2 (en) 2001-03-09 2005-11-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
US7022728B2 (en) 2001-03-09 2006-04-04 Abbott Laboratories Benzimidazoles that are useful in treating male sexual dysfunction
US20030008878A1 (en) * 2001-03-09 2003-01-09 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
US20020169166A1 (en) * 2001-03-09 2002-11-14 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
AU655420B2 (en) * 1990-04-25 1994-12-22 Vivus, Inc. Treatment of erectile dysfunction
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
NZ500921A (en) * 1997-05-19 2002-11-26 Zonagen Inc Composition containing a-adrenergic antagonist and a phosphodiesterase inhibitor or a dopaminergic agonist for modulating the human sexual response

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775102B2 (en) * 1999-09-13 2004-07-15 David M. Swope Composition and method for decreasing neurologic symptomatology

Also Published As

Publication number Publication date
WO2000023056A2 (en) 2000-04-27
WO2000023056A3 (en) 2000-08-24
CA2251255A1 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
HUP0100460A3 (en) Glucocorticoid-selective anti-inflammatory agents
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU4814599A (en) Novel compounds useful in pain management
AU4814899A (en) Novel compounds useful in pain management
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
AU4900797A (en) Conformationally restricted polyamines and their use as antineoplastic agents
AU2841801A (en) Triazolotriazinones and the use thereof
AU5056099A (en) Compounds for use in the treatment of inflammation
AU6321899A (en) The use of dopaminergic agents in the management of sexual dysfunction
AU4676099A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
AUPP584198A0 (en) New use
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU2641199A (en) Remedies for erectile dysfunction
ZA992192B (en) Humectant and lubricant solution for ophthalmic use.
AU3843600A (en) Bath equipped with water vibrator and therapeutic method using the same
PL343428A1 (en) New contraceptive kit
AU6235799A (en) New use
AU2134900A (en) Novel oxo-aminotetralin compounds useful in pain management
AU6898498A (en) Use of mkc-442 in combination with other antiviral agents
AU6733500A (en) Agents for ameliorating erectile dysfunction
GB9803005D0 (en) Anti-inflammatory agents
AU2574699A (en) Use of extracts from aristolochia in the treatment of aids
GB9825969D0 (en) Agents useful in the treatment of reproductive disorders
GB9911178D0 (en) Agents useful in the treatment of reproductive disorders
AU6409598A (en) An improvement in the treatment of wastes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase